Phase 1 Lung Cancers Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Early Phase Study of KESONOTIDE™in Participants With Solid Tumours

Breast CancerLung CancersOvarian Cancer+4 more

Filamon LTD80 enrolled3 locationsNCT06926075

Recruiting

Phase 1Phase 2

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Lung CancersLocally AdvancedSolid Tumor Cancer+2 more

Avenzo Therapeutics, Inc.430 enrolled16 locationsNCT07038343

Recruiting

Phase 1

An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors

Lung CancersSarcomaMelanoma

Guangzhou FineImmune Biotechnology Co., LTD.15 enrolled1 locationNCT06942143